Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $246.09 million as of February 20, 2026. Its market cap has increased by 25.17% in one year.

• Market Cap: 246.09M
• Enterprise Value: 224.90M
• 1-Year Change: 25.17%
• Ranking: #3672
• Category: Micro-Cap
• Stock Price: $3.06

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $246.09M, an increase of 1,985.50%. That is a compound annual growth rate of 11.80%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2026	246.10M	69.96%
Dec 31, 2025	144.80M	4.62%
Dec 31, 2024	138.40M	6.54%
Dec 29, 2023	129.90M	87.18%
Dec 30, 2022	69.40M	83.11%
Dec 31, 2021	37.90M	-68.68%
Dec 31, 2020	121.00M	148.46%
Dec 31, 2019	48.70M	5.64%
Dec 31, 2018	46.10M	-50.11%
Dec 29, 2017	92.40M	107.64%
Dec 30, 2016	44.50M	-56.29%
Dec 31, 2015	101.80M	-40.95%
Dec 31, 2014	172.40M	-52.64%
Dec 31, 2013	364.00M	-24.96%
Dec 31, 2012	485.10M	14.93%
Dec 30, 2011	422.10M	-47.92%
Dec 31, 2010	810.50M	58.46%
Dec 31, 2009	511.50M	266.14%
Dec 31, 2008	139.70M	-45.71%
Dec 31, 2007	257.30M	2,552.58%
Dec 29, 2006	9.70M	-21.77%
Dec 30, 2005	12.40M	1,671.43%
Dec 31, 2004	700.00K	-41.67%
Dec 31, 2003	1.20M	300.00%
Dec 31, 2002	300.00K	-57.14%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Shattuck Labs	253.75M
Larimar Therapeutics	252.49M
Palisade Bio	251.82M
Inhibikase Therapeutics	246.21M
OmniAb	246.16M
Coherus Oncology	243.64M
Silence Therapeutics	229.56M
Nuvectis Pharma	228.62M